Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial

Autor Gertz, Morie A., Abonour, Rafat, Heffner, Leonard T., Greipp, Philip R., Uno, Hajime, Rajkumar, S. V.
Vydáno 2009

Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation

Autor Jillella, Anand P., Arellano, Martha L., Heffner, Leonard T., Gaddh, Manila, Langston, Amelia A., Khoury, Hanna J., Mangoankar, Abhishek, Kota, Vamsi K.
Vydáno v Hematol Rep (2017)

ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation

Autor Jillella, Anand P., Arellano, Martha L., Heffner, Leonard T., Gaddh, Manila, Langston, Amelia A., Khoury, Hanna J., Mangaonkar, Abhishek, Kota, Vamsi K.
Vydáno v Hematol Rep (2019)

Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200

Autor Mahadevan, Daruka, Lanasa, Mark C., Farber, Charles, Pandey, Manjari, Whelden, Maria, Faas, Susan J., Ulery, Terrie, Kukreja, Anjli, Li, Lan, Bedrosian, Camille L., Zhang, Xiaoping, Heffner, Leonard T.
Vydáno v J Immunother Cancer (2019)

Long-Term Follow-Up Results of Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy and Risk-Adapted Maintenance Approach in Newly Diagnosed Multiple Myeloma

Autor Joseph, Nisha S., Kaufman, Jonathan L., Dhodapkar, Madhav V., Hofmeister, Craig C., Almaula, Dhwani K., Heffner, Leonard T., Gupta, Vikas A., Boise, Lawrence H., Lonial, Sagar, Nooka, Ajay K.
Vydáno v J Clin Oncol (2020)

Phase 1 Multicenter Study of Vincristine Sulfate Liposomes Injection and Dexamethasone in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Autor Thomas, Deborah A., Kantarjian, Hagop M., Stock, Wendy, Heffner, Leonard T., Faderl, Stefan, Garcia-Manero, Guillermo, Ferrajoli, Alessandra, Wierda, William, Pierce, Sherry, Lu, Biao, Deitcher, Steven R., O’Brien, Susan
Vydáno v Cancer (2009)

Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B‐cell receptor pathway inhibitor

Autor Wierda, William G., Byrd, John C., Davids, Matthew S., Furman, Richard R., Cheson, Bruce D., Barr, Paul M., Eradat, Herbert, Heffner, Leonard, Zhou, Lang, Verdugo, Maria, Potluri, Jalaja, Choi, Michael
Vydáno v Br J Haematol (2018)

Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma

Autor Matulis, Shannon M., Gupta, Vikas A., Neri, Paola, Bahlis, Nizar J., Maciag, Paulo, Leverson, Joel D., Heffner, Leonard T., Lonial, Sagar, Nooka, Ajay K., Kaufman, Jonathan L., Boise, Lawrence H.
Vydáno v Leukemia (2019)

Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors

Autor Kong, Jee Hyun, Winton, Elliott F., Heffner, Leonard T., Gaddh, Manila, Hill, Brittany, Neely, Jessica, Hatcher, Angela, Joseph, Meena, Arellano, Martha, El-Rassi, Fuad, Kim, Audrey, Khoury, Jean Hanna, Kota, Vamsi K.
Vydáno v J Clin Med (2020)

Combining carfilzomib and panobinostat to treat relapsed/refractory multiple myeloma: results of a Multiple Myeloma Research Consortium Phase I Study

Autor Kaufman, Jonathan L., Mina, Roberto, Jakubowiak, Andrzej J., Zimmerman, Todd L., Wolf, Jeffrey J., Lewis, Colleen, Gleason, Charise, Sharp, Cathy, Martin, Thomas, Heffner, Leonard T., Nooka, Ajay K., Harvey, R. Donald, Lonial, Sagar
Vydáno v Blood Cancer J (2019)

Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy

Autor Coutre, Steven, Choi, Michael, Furman, Richard R., Eradat, Herbert, Heffner, Leonard, Jones, Jeffrey A., Chyla, Brenda, Zhou, Lang, Agarwal, Suresh, Waskiewicz, Tina, Verdugo, Maria, Humerickhouse, Rod A., Potluri, Jalaja, Wierda, William G., Davids, Matthew S.
Vydáno v Blood (2018)

Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia

Autor Jain, Nitin, Stock, Wendy, Zeidan, Amer, Atallah, Ehab, McCloskey, James, Heffner, Leonard, Tomlinson, Benjamin, Bhatnagar, Bhavana, Feingold, Jay, Ungar, David, Chao, Grace, Zhang, Xiaoyan, Qin, Yajuan, Havenith, Karin, Kantarjian, Hagop, Wieduwilt, Matthew J.
Vydáno v Blood Adv (2020)

Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia

Autor Gökbuget, Nicola, Kantarjian, Hagop M., Brüggemann, Monika, Stein, Anthony S., Bargou, Ralf C., Dombret, Hervé, Fielding, Adele K., Heffner, Leonard, Rigal-Huguet, Françoise, Litzow, Mark, O’Brien, Susan, Zugmaier, Gerhard, Gao, Shan, Nagorsen, Dirk, Forman, Stephen J., Topp, Max S.
Vydáno v Blood Adv (2019)

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients with Previously Untreated Indolent non-Hodgkin’s Lymphoma...

Autor Cohen, Jonathon B., Switchenko, Jeffrey M., Koff, Jean L., Sinha, Rajni, Kaufman, Jonathan L., Khoury, H. Jean, Bumpers, Nassoma, Colbert, Amanda, Hutchison-Rzepka, Amanda, Nastoupil, Loretta J., Heffner, Leonard T., Langston, Amelia, Lechowicz, Mary Jo, Lonial, Sagar, Flowers, Christopher R.
Vydáno v Br J Haematol (2015)

Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis

Autor Reece, Donna E., Hegenbart, Ute, Sanchorawala, Vaishali, Merlini, Giampaolo, Palladini, Giovanni, Bladé, Joan, Fermand, Jean-Paul, Hassoun, Hani, Heffner, Leonard, Kukreti, Vishal, Vescio, Robert A., Pei, Lixia, Enny, Christopher, Esseltine, Dixie-Lee, van de Velde, Helgi, Cakana, Andrew, Comenzo, Raymond L.
Vydáno 2014

Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy

Autor Mato, Anthony R., Wierda, William G., Davids, Matthew S., Cheson, Bruce D., Coutre, Steven E., Choi, Michael, Furman, Richard R., Heffner, Leonard, Barr, Paul M., Eradat, Herbert, Ford, Sharanya M., Zhou, Lang, Verdugo, Maria, Humerickhouse, Rod A., Potluri, Jalaja, Byrd, John C.
Vydáno v Haematologica (2019)

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone

Autor Schmidt, Timothy M., Barwick, Benjamin G., Joseph, Nisha, Heffner, Leonard T., Hofmeister, Craig C., Bernal, Leon, Dhodapkar, Madhav V., Gupta, Vikas A., Jaye, David L., Wu, Jiayi, Goyal, Subir, Chen, Zhengjia, Boise, Lawrence H., Lonial, Sagar, Nooka, Ajay K., Kaufman, Jonathan L.
Vydáno v Blood Cancer J (2019)

Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma

Autor Hamadani, Mehdi, Radford, John, Carlo-Stella, Carmelo, Caimi, Paolo F., Reid, Erin, O’Connor, Owen A., Feingold, Jay M., Ardeshna, Kirit M., Townsend, William, Solh, Melhem, Heffner, Leonard T., Ungar, David, Wang, Luqiang, Boni, Joseph, Havenith, Karin, Qin, Yajuan, Kahl, Brad S.
Vydáno v Blood (2021)

Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma

Autor Lonial, Sagar, Waller, Edmund K., Richardson, Paul G., Jagannath, Sundar, Orlowski, Robert Z., Giver, Cynthia R., Jaye, David L., Francis, Dixil, Giusti, Sara, Torre, Claire, Barlogie, Bart, Berenson, James R., Singhal, Seema, Schenkein, David P., Esseltine, Dixie-Lee W., Anderson, Jessica, Xiao, Hugh, Heffner, Leonard T., Anderson, Kenneth C.
Vydáno 2005

High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia

Autor O'Brien, Susan, Schiller, Gary, Lister, John, Damon, Lloyd, Goldberg, Stuart, Aulitzky, Walter, Ben-Yehuda, Dina, Stock, Wendy, Coutre, Steven, Douer, Dan, Heffner, Leonard T., Larson, Melissa, Seiter, Karen, Smith, Scott, Assouline, Sarit, Kuriakose, Philip, Maness, Lori, Nagler, Arnon, Rowe, Jacob, Schaich, Markus, Shpilberg, Ofer, Yee, Karen, Schmieder, Guenter, Silverman, Jeffrey A., Thomas, Deborah, Deitcher, Steven R., Kantarjian, Hagop
Vydáno v J Clin Oncol (2013)